Nature Immunology
2, 473 - 475 (2001)
doi:10.1038/88656
Immune control of HIV: the obstacles of HLA and viral diversityBruce D. Walker1
& Bette T. Korber21
Partners AIDS Research Center, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, MA 02114, USA. 2
Los Alamos National Laboratory, Los Alamos, NM 87545, USA. (bwalker@helix.mgh.harvard.edu) The development of an effective vaccine for HIV requires a better understanding of immune responses. The challenge is to contain HIV in the context of individual host genetics and the ever increasing diversity of HIV.
|
